Veterinary Foresight and Expertise in Antimicrobial Discussions

Comment on this policy

The AVMA should be at the forefront of discussions that may impact drug availability, such as regulatory changes in veterinary oversight especially pertaining to antimicrobial use. The AVMA must:

  • Proactively engage stakeholders and aggressively pursue opportunities to participate in and, where appropriate, lead those discussions.
  • Make certain that decisions are informed by science.
  • Ensure that risks and benefits to both humans and animals are given due consideration.
  • Strive to minimize the potential for unintended negative consequences and maximize potential benefits.
  • Incorporate members' expertise to effectively advocate for the veterinary profession, the animals in its care, and the public whose health veterinarians safeguard.

Relevant AVMA Policy: